Petra Kleiblová

Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families

Xin Yang, Goska Leslie, Alicja Doroszuk et al. · Journal of Clinical Oncology · 2019 · 418 citations · Full text

Life Sciences, Genetics, Oncology +17

Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint

Petra Kleiblová, Indra A. Shaltiël, Jan Benada et al. · The Journal of Cell Biology · 2013 · 171 citations · Full text

Life Sciences, Genetics, Oncology +17

Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus

Petra Kleiblová, I Dostálová, Markéta Bártlová et al. · Molecular and Cellular Endocrinology · 2009 · 107 citations

Medicine, Endocrinology, Obstetrics +16

Identification of deleterious germline <i>CHEK2</i> mutations and their association with breast and ovarian cancer

Petra Kleiblová, Lenka Stolařová, Kateřina Křížová et al. · International Journal of Cancer · 2019 · 89 citations

Medicine, Genetics, Oncology +17

Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3

Soňa Pecháčková, Kamila Burdová, Jan Benada et al. · Oncotarget · 2016 · 73 citations · Full text

Life Sciences, Molecular Biology, Oncology +17